TomTom NV (TOM2):企業の財務・戦略的SWOT分析

◆英語タイトル:TomTom NV (TOM2) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15830
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:技術・通信
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

TomTom NV (TOM2) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

TomTom NV (TomTom) designs and develops navigation and mapping products. The company offers navigation and digital mapping devices, and traffic, and software for car manufacturers; and GPS sports watches, fleet management solutions, and location-based products for runners, cyclists, and swimmers. It also provides cloud-based products to create location-enabled applications for the government, and business organizations. TomTom also provides vehicle telematics, fleet management, and connected car services for enhancing the vehicle performance, save fuel and increase fleet efficiency. The company serves its products and services to business organizations and government, automotive, and telematics sectors. TomTom is headquartered in Amsterdam, the Netherlands.

TomTom NV Key Recent Developments

Sep 05,2018 TOPC : TomTom teams with rideOS to Integrate Its Real-Time Traffic Data Into Next-Generation Transportation Platform[Newswire : MarketLine - BW]
Jun 07,2018 TomTom appoints new Head of Investor Relations

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
TomTom NV – Key Facts
TomTom NV – Key Employees
TomTom NV – Key Employee Biographies
TomTom NV – Major Products and Services
TomTom NV – History
TomTom NV – Company Statement
TomTom NV – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
TomTom NV – Business Description
Business Segment: Automotive and Enterprise
Overview
Performance
Business Segment: Consumer
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: North America
Performance
Geographical Segment: Rest of World
Performance
TomTom NV – Corporate Strategy
TomTom NV – SWOT Analysis
SWOT Analysis – Overview
TomTom NV – Strengths
TomTom NV – Weaknesses
TomTom NV – Opportunities
TomTom NV – Threats
TomTom NV – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
TomTom NV, Recent Deals Summary
Section 4 – Company’s Recent Developments
Sep 05, 2018: TOPC : TomTom teams with rideOS to Integrate Its Real-Time Traffic Data Into Next-Generation Transportation Platform[Newswire : MarketLine - BW]
Jun 07, 2018: TomTom appoints new Head of Investor Relations
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
TomTom NV, Key Facts
TomTom NV, Key Employees
TomTom NV, Key Employee Biographies
TomTom NV, Major Products and Services
TomTom NV, History
TomTom NV, Other Locations
TomTom NV, Subsidiaries
TomTom NV, Key Competitors
TomTom NV, Ratios based on current share price
TomTom NV, Annual Ratios
TomTom NV, Annual Ratios (Cont...1)
TomTom NV, Annual Ratios (Cont...2)
TomTom NV, Interim Ratios
TomTom NV, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
TomTom NV, Performance Chart (2014 - 2018)
TomTom NV, Ratio Charts

★海外企業調査レポート[TomTom NV (TOM2):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Exterran Corp (EXTN):企業の財務・戦略的SWOT分析
    Exterran Corp (EXTN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Lidds AB (LIDDS):製薬・医療:M&Aディール及び事業提携情報
    Summary Lidds AB (Lidds) is a developer of pharmaceutical products for the treatment of cancer and other diseases. The company offers Liproca Depot, an injectable product used for the treatment of prostate cancer. Its Liproca is a bioresorbable, biocompatible and locally injectable modified release …
  • Biocurv Medical Instruments, Inc.:企業の戦略・SWOT・財務情報
    Biocurv Medical Instruments, Inc. - Strategy, SWOT and Corporate Finance Report Summary Biocurv Medical Instruments, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Keepmoat Ltd:企業の戦略的SWOT分析
    Keepmoat Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Farmer Bros. Co. (FARM):企業の財務・戦略的SWOT分析
    Farmer Bros. Co. (FARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Charles River Laboratories International Inc (CRL):製薬・医療:M&Aディール及び事業提携情報
    Summary Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. Th …
  • SynCore Biotechnology Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary SynCore Biotechnology Co Ltd (SynCore), a subsidiary of Sinphar Pharmaceutical Co Ltd is a biopharmaceutial company that utilizes and in-licenses technologies to develop new drugs. The company’s pipeline products include SB01, SB02, SB03, SB04 and SB05. Its SB01 drug is a new chemical entity …
  • United Community Banks Inc:企業のM&A・事業提携・投資動向
    United Community Banks Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's United Community Banks Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • University of Alabama at Birmingham-製薬・医療分野:企業M&A・提携分析
    Summary University of Alabama at Birmingham (UAB), a subsidiary of University of Alabama System is an educational university that offers undergraduate and graduate programs. The university provides graduate programs in arts and sciences, health professions, medicine, nursing, business, dentistry, ed …
  • SK Telecom Co., Ltd.:企業の戦略・SWOT・財務分析
    SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Sandvik AB:企業の戦略・SWOT・財務情報
    Sandvik AB - Strategy, SWOT and Corporate Finance Report Summary Sandvik AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Abdullah Al-Othaim Markets Co.:企業の戦略・SWOT・財務情報
    Abdullah Al-Othaim Markets Co. - Strategy, SWOT and Corporate Finance Report Summary Abdullah Al-Othaim Markets Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Merck & Co., Inc.:企業のM&A・事業提携・投資動向
    Merck & Co., Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Merck & Co., Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Leadiant Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Leadiant Biosciences Inc (Leadiant Biosciences), formerly Sigma-Tau Pharmaceuticals Inc, a subsidiary of Leadiant Biosciences SpA, is a pharmaceutical company that discovers and develops novel medicines. The company provides products such as abelcet, adagen, carnitor, cystaran, depocyt, matu …
  • Vitasoy International Holdings Ltd (0345)
    Vitasoy International Holdings Ltd (0345) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Nidek Co Ltd:製品パイプライン分析
    Summary Nidek Co Ltd (Nidek) is a medical device company that designs, manufactures, distributes and leases ophthalmic and diagnostic equipment. Its products category encompasses ophthalmology and optometry software for advanced angioscan; lens edging technology for manufacturing eyeglasses, and sem …
  • BP Plc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    BP Plc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary BP Plc (BP) is an integrated oil and gas company. Its upstream activities include exploration, development and production of oil and natural gas, field development and production; and midstream operations inc …
  • Walmart Inc:企業のM&A・事業提携・投資動向
    Walmart Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Walmart Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Hormel Foods Corp:企業の戦略・SWOT・財務情報
    Hormel Foods Corp - Strategy, SWOT and Corporate Finance Report Summary Hormel Foods Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Chronos Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Chronos Therapeutics Ltd (Chronos) is a research company that offers drug discovery and development services. The company offers research and development, drug discovery, lead optimization, preclinical efficacy, IND enabling, screening, pipeline development and clinical trial services. Its p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆